Related Experiment Video

Updated: Aug 16, 2025

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
10:03

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

5.4K

Conventional Biomarkers for Predicting Clinical Outcomes in Patients with Heart Disease

Ion-Bogdan Mănescu1,2, Krisztina Pál1,2, Silvia Lupu3,4

  • 1Clinical Laboratory, County Emergency Clinical Hospital of Targu Mures, 540136 Targu Mures, Romania.

Life (Basel, Switzerland)
|December 23, 2022
PubMed

Insights

This review explores recent advancements in using humoral biomarkers for assessing cardiovascular disease risk. Accurate risk assessment aids in managing heart disease and preventing major adverse cardiovascular events.

Area of Science:

  • Cardiology
  • Biomarker Research
  • Preventive Medicine

Background:

  • Atherosclerosis is a primary driver of global cardiovascular disease.
  • Coronary atherosclerosis progression causes coronary artery disease, leading to myocardial ischemia.
  • Acute coronary syndromes and heart failure post-myocardial infarction are severe complications of coronary artery disease.

Purpose of the Study:

  • To review recent findings on humoral biomarkers for risk assessment in heart disease patients.
  • To highlight the role of biomarkers in improving cardiovascular disease management.
  • To discuss strategies for preventing major cardiovascular events.

Main Methods:

  • Literature review of recent studies on humoral biomarkers.
  • Analysis of validated risk assessment tools including biomarkers and clinical scores.
  • Synthesis of current research on biomarker utility in cardiology.

Main Results:

  • Humoral biomarkers, alongside imaging and clinical scores, are established tools for risk stratification.
  • Ongoing research continues to refine the application of biomarkers in clinical practice.
  • Recent findings offer new insights into the predictive value of specific biomarkers.

Conclusions:

  • Humoral biomarkers are crucial for accurate risk assessment in patients with heart disease.
  • Effective risk assessment using biomarkers can improve patient outcomes and reduce cardiovascular events.
  • Continued research is essential for optimizing the use of biomarkers in cardiovascular medicine.

Keywords:
acute coronary syndromebiomarkerscoronary artery diseaseheart failure

More Related Videos

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

36.6K
Author Spotlight: Exercise Test for Evaluation of the Functional Efficacy of the Pig Cardiovascular System02:47

Author Spotlight: Exercise Test for Evaluation of the Functional Efficacy of the Pig Cardiovascular System

Published on: May 12, 2023

1.4K

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
138
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
229
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
20
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
56
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
46
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
24